Search

Niv Papo

from Palo Alto, CA
Age ~52
Get Report
Connected to:
Amanda J Papo, 35Bernard J Papo, 85Cruz Papo, 46Jennifer A Papoccia, 42Kirsten J Papocchia, 34Galena J Papoi, 61Steve K Papoi, 109Anthony J Papola, 72Taylor A Papola, 26William A Papon, 70

Niv Papo Phones & Addresses

  • 420 James Rd, Palo Alto, CA 94306
  • 734 Encina Grande Dr, Palo Alto, CA 94306

Publications

Us Patents

Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 And Alpha V Beta 3 Integrin

View page
US Patent:
20120020889, Jan 26, 2012
Filed:
Jan 18, 2010
Appl. No.:
13/145059
Inventors:
Jennifer R. Cochran - Stanford CA, US
Adam Silverman - Redwood City CA, US
Douglas Jones - Cambridge MA, US
Niv Papo - Palo Alto CA, US
International Classification:
A61K 49/00
A61K 38/18
C12N 15/62
C12N 5/071
A61P 17/06
C40B 30/04
A61P 35/00
A61P 27/02
A61P 19/02
C07K 19/00
G01N 33/574
US Classification:
424 91, 530399, 514 81, 536 234, 435375, 435 723, 506 9
Abstract:
Polypeptides comprising variant vascular endothelial growth factor sequences are provided. The polypeptides are useful in cancer imaging, cancer diagnosis, monitoring and treatment as well as treatment of diseases characterized by excessive neovascularization.

Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 And Alpha V Beta 3 Integrin

View page
US Patent:
20190048051, Feb 14, 2019
Filed:
Oct 25, 2018
Appl. No.:
16/170310
Inventors:
- Stanford CA, US
Adam Silverman - Redwood City CA, US
Douglas Jones - Newton MA, US
Niv Papo - Palo Alto CA, US
International Classification:
C07K 14/475
C07K 14/515
A61K 38/18
Abstract:
Polypeptides comprising variant vascular endothelial growth factor sequences are provided. The polypeptides are useful in cancer imaging, cancer diagnosis, monitoring and treatment as well as treatment of diseases characterized by excessive neovascularization.

Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 And Alpha V Beta 3 Integrin

View page
US Patent:
20160039895, Feb 11, 2016
Filed:
Aug 17, 2015
Appl. No.:
14/828319
Inventors:
- Stanford CA, US
Adam Silverman - Redwood City CA, US
Douglas Jones - Newton MA, US
Niv Papo - Palo Alto CA, US
International Classification:
C07K 14/475
Abstract:
Polypeptides comprising variant vascular endothelial growth factor sequences are provided. The polypeptides are useful in cancer imaging, cancer diagnosis, monitoring and treatment as well as treatment of diseases characterized by excessive neovascularization.

Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 And Alpha V Beta 3 Integrin

View page
US Patent:
20160039896, Feb 11, 2016
Filed:
Aug 17, 2015
Appl. No.:
14/828330
Inventors:
- Standford CA, US
Adam Silverman - Redwood City CA, US
Douglas Jones - Newton MA, US
Niv Papo - Palo Alto CA, US
International Classification:
C07K 14/475
Abstract:
Polypeptides comprising variant vascular endothelial growth factor sequences are provided. The polypeptides are useful in cancer imaging, cancer diagnosis, monitoring and treatment as well as treatment of diseases characterized by excessive neovascularization.

Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 And Alpha V Beta 3 Integrin

View page
US Patent:
20150037888, Feb 5, 2015
Filed:
Oct 9, 2014
Appl. No.:
14/510886
Inventors:
- Palo Alto CA, US
Adam Silverman - Redwood City CA, US
Douglas Jones - Newton MA, US
Niv Papo - Palo Alto CA, US
International Classification:
C07K 14/515
US Classification:
435375, 530399, 536 234
Abstract:
Polypeptides comprising variant vascular endothelial growth factor sequences are provided. The polypeptides are useful in cancer imaging, cancer diagnosis, monitoring and treatment as well as treatment of diseases characterized by excessive neovascularization.

Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 And Alpha V Beta 3 Integrin

View page
US Patent:
20150037889, Feb 5, 2015
Filed:
Oct 9, 2014
Appl. No.:
14/510894
Inventors:
- Palo Alto CA, US
Adam Silverman - Redwood City CA, US
Douglas Jones - Newton MA, US
Niv Papo - Palo Alto CA, US
International Classification:
C07K 14/475
US Classification:
435375
Abstract:
Polypeptides comprising variant vascular endothelial growth factor sequences are provided. The polypeptides are useful in cancer imaging, cancer diagnosis, monitoring and treatment as well as treatment of diseases characterized by excessive neovascularization.

Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 And Alpha V Beta 3 Integrin

View page
US Patent:
20150005235, Jan 1, 2015
Filed:
Sep 3, 2014
Appl. No.:
14/476551
Inventors:
- PALO ALTO CA, US
Adam Silverman - Redwood City CA, US
Douglas Jones - Newton MA, US
Niv Papo - Palo Alto CA, US
International Classification:
C07K 14/475
US Classification:
514 81, 530399, 536 2351
Abstract:
Polypeptides comprising variant vascular endothelial growth factor sequences are provided. The polypeptides are useful in cancer imaging, cancer diagnosis, monitoring and treatment as well as treatment of diseases characterized by excessive neovascularization.

Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 And Alpha V Beta 3 Integrin

View page
US Patent:
20140356286, Dec 4, 2014
Filed:
Apr 21, 2014
Appl. No.:
14/257772
Inventors:
- Palo Alto CA, US
Adam Silverman - Redwood City CA, US
Douglas Jones - Newton MA, US
Niv Papo - Palo Alto CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
C07K 14/475
A61K 47/48
A61K 38/18
US Classification:
424 91, 530399, 536 234, 514 81, 435375, 506 9
Abstract:
Polypeptides comprising variant vascular endothelial growth factor sequences are provided. The polypeptides are useful in cancer imaging, cancer diagnosis, monitoring and treatment as well as treatment of diseases characterized by excessive neovascularization.
Control profile
Niv Papo from Palo Alto, CA, age ~52 Get Report